Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
Mehta
J L
JL
Subramanian
V B
VB
D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology / Q000401:mortality*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015201:Meta-Analysis as Topic; D009543:Nifedipine / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D012449:Safety; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D009543:Nifedipine